Lv5
1008 积分 2022-05-29 加入
Newer and novel antidiabetic drug classes across the cardiovascular-kidney-metabolic continuum
6小时前
待确认
Current status and future perspectives of FGF21 analogues in clinical trials
12天前
已完结
Chronic kidney disease in cirrhosis - A study of inpatients from a global perspective
13天前
已完结
Nephrology in the Paradigm of Cardiovascular-Kidney-Metabolic Health: Report of an ASN Initiative on Saving Kidneys, Hearts, and Lives
14天前
已关闭
Understanding MASLD - from molecular pathogenesis to cardiovascular risk: A concise review for the clinical cardiologist
17天前
已完结
The Basics of Metabolic Dysfunction-Associated Steatotic Liver Disease for Cardiologists: Pathophysiology, Diagnosis, and Treatment
17天前
已完结
Liver disease: screening for the elusive adversary
25天前
已完结
HFpEF and MASLD: converging mechanisms and clinical implications
26天前
已完结
Decoding the Liver-Heart Axis in Cardiometabolic Diseases
26天前
已完结
Parental obesity and risk of metabolic dysfunction associated steatotic liver disease in adult offspring: UK birth cohort study
1个月前
已完结
皖公网安备34019202002308
